Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.75 RB, SLActive? 12mm, RXD: medical device reports filed with FDA

4,579 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,579
device reports naming the brand
0% of all MAUDE reports · about 618 a year
1,073
reports, 12 months to August 2026
964 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,579 medical device reports received by FDA name the brand "BLX ?3.75 RB, SLActive? 12mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from February 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,073 reports arrived in the 12 months to August 2026, up 11% from 964 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.2%), loss of osseointegration (15.4%) and difficult to insert (1%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0101202Sep 2021: 24Oct 2021: 49Nov 2021: 49Dec 2021: 322022Jan 2022: 39Feb 2022: 35Mar 2022: 41Apr 2022: 60May 2022: 56Jun 2022: 38Jul 2022: 61Aug 2022: 46Sep 2022: 33Oct 2022: 55Nov 2022: 50Dec 2022: 432023Jan 2023: 51Feb 2023: 57Mar 2023: 55Apr 2023: 64May 2023: 41Jun 2023: 57Jul 2023: 69Aug 2023: 56Sep 2023: 51Oct 2023: 57Nov 2023: 57Dec 2023: 502024Jan 2024: 51Feb 2024: 47Mar 2024: 57Apr 2024: 78May 2024: 75Jun 2024: 57Jul 2024: 71Aug 2024: 74Sep 2024: 67Oct 2024: 103Nov 2024: 125Dec 2024: 662025Jan 2025: 49Feb 2025: 60Mar 2025: 80Apr 2025: 43May 2025: 0Jun 2025: 202Jul 2025: 100Aug 2025: 69Sep 2025: 81Oct 2025: 106Nov 2025: 83Dec 2025: 962026Jan 2026: 63Feb 2026: 64Mar 2026: 111Apr 2026: 99May 2026: 85Jun 2026: 100Jul 2026: 93Aug 2026: 92

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04859692019: 14520192020: 24620202021: 41920212022: 55720222023: 66520232024: 87120242025: 96920252026: 7072026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,579
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84.5%3,868
Voluntary report0%0
User facility report0%0
Distributor report15.5%711
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,35073.2%62.8%
Loss of osseointegration70415.4%22.4%
Difficult to insertthe device was hard to insert471%0.4%
Separation failure100.2%0.1%
Fracturea broken bone90.2%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,56034.1%
Painpain, site not specified95920.9%
Inflammationinflammation2946.4%
Tissue damage2465.4%
Hemorrhage/blood loss/bleeding2184.8%
Swelling/ edema2014.4%
Fistula1212.6%
Hyperresponsive to stimuli1072.3%
Abscessa collection of pus1042.3%
Hypersensitivity/allergic reaction420.9%
Swellingswelling200.4%
Inadequate osseointegration120.3%
Sinus perforation100.2%
Numbnessnumbness90.2%
Failure of implant80.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.75 RB, SLActive? 12mm, RXDProduct code DZEAll MAUDE reports
Reports4,5793,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.75 RB, SLActive? 12mm, RXD reports

How many FDA reports name BLX ?3.75 RB, SLActive? 12mm, RXD?

4,579 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,073 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.2%), loss of osseointegration (15.4%), difficult to insert (1%), separation failure (0.2%) and fracture (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84.5%) and distributor reports (15.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.75 RB, SLActive? 12mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.